The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).
- Citation:
- Leuk Lymphoma vol 54 (2) 252-4
- Year:
- 2013
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 2
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA031946 (Bertagnolli), U10CA033601 (Sargent), U10CA032102 (Baker), U10CA021115 , U10 CA180821, U10 CA180882
- Corr. Author:
- Authors:
- Melhem Solh Kanti R Rai Bercedis L Peterson Jonathan E Kolitz Frederick R Appelbaum Martin S Tallman Andrew Belch Richard A Larson Vicki A Morrison
- Networks:
- Study
- CALGB-9011
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adult, Aged, Antineoplastic Agents, Cell Transformation, Neoplastic, Female, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Male, Middle Aged, Neoplasm Staging, Treatment Outcome, Vidarabine